Zimmer Biomet Holdings Inc (NYSE:ZBH)
$ 121.31 -0.13 (-0.11%) Market Cap: 24.96 Bil Enterprise Value: 30.52 Bil PE Ratio: 26.26 PB Ratio: 1.98 GF Score: 83/100

Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 08:00PM GMT
Release Date Price: $123.11 (-0.98%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to host my next session with Zimmer Biomet. I have the CEO, Bryan Hanson; and the CFO, Suky Upadhyay. I think I was close there. Sorry, Suky. So we're going to diverge a little bit from the format we had for some of the other sessions. We're going to do 20 minutes of Q&A that allows Zimmer Biomet to highlight some of the really key topics today, and then we're going to move into 20 minutes of a little less formal Q&A. Please feel free to submit questions or e-mail me and I can do my best to get to all of them.

Questions & Answers

Robert Justin Marcus;Bryan C. Hanson
JPMorgan Chase & Co, Research Division - Analyst;Zimmer Biomet Holdings, Inc. -

But Bryan, Suky maybe to kick it off, Bryan, you've been at Zimmer Biomet for 4 years now. You've undergone this really big transformation process. Where do you sit now in the total process for Zimmer Biomet?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot